Friday, April 3, 2026

Every story. Every perspective.

◈ Perspectives Politics Economy Finance Technology Climate Science Conflict Culture

Every story. Every perspective.

Sections

Politics
Economy
Finance
Technology
Climate
Science
Conflict
Culture

Languages

🇬🇧 English
🇮🇹 Italiano
🇩🇪 Deutsch
🇫🇷 Français
🇪🇸 Español
🇵🇹 Português
🇳🇱 Nederlands
🇵🇱 Polski
🇷🇺 Русский
🇯🇵 日本語

About

Editorial Policy
How it works
Privacy Policy
Terms & Conditions

© 2026 DDO LTD (MT30710326) — All rights reserved

Content is synthesized automatically from accredited international sources. worldnews.fyi does not claim authorship of original reporting.

⚡ Live

Pfizer-Valneva Lyme disease vaccine shows 70% efficacy despite trial challenges Pfizer-Valneva Lyme disease vaccine shows 70% efficacy despite trial challenges

Tagged: phase 3

← All Stories

3 articles tagged "phase 3"

Pfizer-Valneva Lyme disease vaccine shows 70% efficacy despite trial challenges

Pfizer Valneva Lyme Disease Vaccine 70% Efficacy Clinical Trial Results 2024